Spread into Peritoneal

[claudine]

I just got an email from OncLive with this link, that may be of interest to you nzjez:

https://www.onclive.com/conference-cove ... n-braf-crc

[4us4]

So all went well enough for my Cytoreductive surgery with HIPEC on the 9th Nov. My surgery was an open surgery (there was mention initially of laparoscopic being possible), and took under 6 hours (including the HIPEC).

Just a note to say I had HIPEC and Cytoreducutive on 11/7/19. Almost twins!

[Rock_Robster]

I just got an email from OncLive with this link, that may be of interest to you nzjez:

https://www.onclive.com/conference-cove ... n-braf-crc

This is a good one to follow. However it is using BEACON in the second or even third-line setting so don’t pay too much attention to the absolute survival numbers. You may want to keep a close eye on ANCHOR as well as this is using the BEACON triplet in the first line / untreated patients (from your signature it doesn’t sound like you progressed on CAPOX which is good).

https://clinicaltrials.gov/ct2/show/NCT03693170

Rob

[nzjez]

I just got an email from OncLive with this link, that may be of interest to you nzjez:

https://www.onclive.com/conference-cove ... n-braf-crc

Hey Claudine
Thanks for thinking of me and posting the link. This triplet/doublet regimen sounds like they way forward.
Cheers
Jeremy

[nzjez]

So all went well enough for my Cytoreductive surgery with HIPEC on the 9th Nov. My surgery was an open surgery (there was mention initially of laparoscopic being possible), and took under 6 hours (including the HIPEC).

Just a note to say I had HIPEC and Cytoreducutive on 11/7/19. Almost twins!

Almost twins alright. I was dx at 39 too, and have 2 kids.
Hope you getting on ok, and the chemo regime is being kind

[nzjez]

I just got an email from OncLive with this link, that may be of interest to you nzjez:

https://www.onclive.com/conference-cove ... n-braf-crc

This is a good one to follow. However it is using BEACON in the second or even third-line setting so don’t pay too much attention to the absolute survival numbers. You may want to keep a close eye on ANCHOR as well as this is using the BEACON triplet in the first line / untreated patients (from your signature it doesn’t sound like you progressed on CAPOX which is good).

https://clinicaltrials.gov/ct2/show/NCT03693170

Rob

Hey Rob
Yeah, apart from mytomicin c in my HIPEC there has been no chemo since my CAPOX regime (after my Stage 3c hemicolectomy).
Hopefully can keep the nasties at bay, and will try and monitor results from the ANCHOR trial. Curious to know if the doublet is better from the start or 2nd/3rd line.
Cheers
Jeremy